PINK:MRZM

Marizyme Stock Insider Trading

> Biotechnology

Buy MRZM

*Your capital is at risk

$0.0003

+0 (+0%)

At Close: Jun 03, 2026

Marizyme Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 17.73M and sold 13.3M MRZM shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	0
● Buy	17.73M shares
● Sell	13.3M shares
84% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 05, 2024 Buy	Options	Kampf Julie B. Director	Director	125 000 Value: $156.3K
Mar 05, 2024 Buy	Options	Kampf Julie B. Director	Director	125 000 Value: $156.3K
Mar 04, 2024 Buy	Options	Dhaduk Vithalbhai D Director	Director	125 000 Value: $156.3K
Mar 04, 2024 Buy	Options	Dhaduk Vithalbhai D Director	Director	125 000 Value: $156.3K
Dec 21, 2023 Sell	Common stock C-Conversion	Braeden Lichti 10 Percent Owner	10% Owner	3 815 294 Value: $381.5K
Dec 21, 2023 Sell	10% Secured Convertible Promissory Note C-Conversion	Braeden Lichti 10 Percent Owner	10% Owner	2 Value: $0
Dec 21, 2023 Sell	10% Secured Convertible Promissory Note C-Conversion	Braeden Lichti 10 Percent Owner	10% Owner	2 Value: $0
Dec 21, 2023 Sell	Common stock C-Conversion	Braeden Lichti 10 Percent Owner	10% Owner	3 815 294 Value: $381.5K
Nov 30, 2023 Buy	Options	Brooks Steven Scott Chief Medical Officer	Officer	40 000 Value: $50.0K
Nov 30, 2023 Buy	Options	Brooks Steven Scott Chief Medical Officer	Officer	40 000 Value: $50.0K
Nov 30, 2023 Buy	Options	Very Donald Leroy Jr Executive Vice President	CEO / President	40 000 Value: $50.0K
Nov 30, 2023 Buy	Options	Very Donald Leroy Jr Executive Vice President	CEO / President	40 000 Value: $50.0K
Oct 31, 2023 Buy	Options	Campbell Neil J Chief Executive Officer	CEO / President	500 000 Value: $625.0K
Oct 31, 2023 Buy	Options	Campbell Neil J Chief Executive Officer	CEO / President	500 000 Value: $625.0K
Aug 29, 2023 Sell	Common shares S-Sale	Lichti Braeden 10 Percent Owner	10% Owner	105 000 Value: $17.3K
Aug 29, 2023 Sell	Common shares S-Sale	Lichti Braeden 10 Percent Owner	10% Owner	105 000 Value: $17.3K
Aug 29, 2023 Buy	Common shares P-Purchase	Lichti Braeden 10 Percent Owner	10% Owner	105 000 Value: $17.3K
Aug 29, 2023 Buy	Common shares P-Purchase	Lichti Braeden 10 Percent Owner	10% Owner	105 000 Value: $17.3K
Jul 07, 2023 Sell	Common shares S-Sale	Lichti Braeden 10 Percent Owner	10% Owner	97 000 Value: $10K
Jul 07, 2023 Sell	Common shares S-Sale	Lichti Braeden 10 Percent Owner	10% Owner	97 000 Value: $10K
Jul 07, 2023 Buy	Common shares P-Purchase	Lichti Braeden 10 Percent Owner	10% Owner	97 000 Value: $10K
Jul 07, 2023 Buy	Common shares P-Purchase	Lichti Braeden 10 Percent Owner	10% Owner	97 000 Value: $10K
Jun 29, 2023 Sell	Common shares S-Sale	Lichti Braeden 10 Percent Owner	10% Owner	106 327 Value: $10K
Jun 29, 2023 Sell	Common shares S-Sale	Lichti Braeden 10 Percent Owner	10% Owner	106 327 Value: $10K
Jun 29, 2023 Buy	Common shares P-Purchase	Lichti Braeden 10 Percent Owner	10% Owner	106 327 Value: $10K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT MARIZYME, INC.

Marizyme, Inc., a life science company, engages in the development and commercialization of medical technologies business. It offers DuraGraft, a one-time intraoperative vascular graft treatment for use in vascular and bypass surgeries that maintains endothelial function and structure, and other related properties. The company also develops various products using its Krillase protease-based therapeutic platform for treating complex wounds and bur...

Read Full Profile Here